CIK: 0001664974 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $86,898 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $31,429 | 36.2% | $18.82 | -61.3% | CL A | 75629V104 |
| EVLV | Evolv Technologies Holdings, Inc. | 9,681,281 | $30,206 | 34.8% | $5.61 | -37.4% | COM CL A | 30049H102 |
| — | Rocket Lab USA, Inc. | 1,377,943 | $24,638 | 28.4% | $4.04 | — | COM | 773122106 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $587 | 0.7% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $39 | 0.0% | $5.56 | +94.4% | SHS | G76279101 |